Search

everythinglearnresearchcommunity

for

Search:↓

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Lower hair zinc and copper levels found in Turkish males with hair loss; higher BMI linked to less hair zinc.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Genetically-altered adult stem cells can help in wound healing and are becoming crucial in regenerative medicine and drug design.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Caffeine applied to the scalp can protect hair follicles from UV damage.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Hair follicle stem cells and skin cells show promise for hair and skin therapies but need more research for clinical use.

Dogs could be good models for studying human hair growth and hair loss.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Caspases do more than kill cells; they also help in cell growth and disease, and targeting them could lead to new treatments.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

Testosterone may both worsen and protect against COVID-19 effects in men.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

The gel with apocynin-loaded nanoparticles shows promise for treating rheumatoid arthritis.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Certain nutrients can help keep skin healthy as we age.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

The document concludes that more research is needed to understand airway repair and to improve tissue engineering for lung treatments.